Sibutramine and blood pressure: a therapeutic dilemma
- 1 January 2002
- journal article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 16 (1) , 1-3
- https://doi.org/10.1038/sj.jhh.1001297
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJournal of Human Hypertension, 2002
- Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitorsJournal of Human Hypertension, 2002
- A clinical trial of the use of Sibutramine for the treatment of patients suffering essential obesityInternational Journal of Obesity, 2000
- Orlistat in the Long-term Treatment of Obesity in Primary Care SettingsArchives of Family Medicine, 2000
- Overweight and obesity in the United States: prevalence and trends, 1960–1994International Journal of Obesity, 1997
- Weight Loss Intervention in Phase 1 of the Trials of Hypertension PreventionArchives of internal medicine (1960), 1993
- Randomized clinical trials of weight reduction in nonhypertensive personsAnnals of Epidemiology, 1991
- The Hypertension Prevention Trial: Three-Year Effects of Dietary Changes on Blood PressureArchives of internal medicine (1960), 1990
- INTERSALT study findings. Public health and medical care implications.Hypertension, 1989
- Comparison of continuous and intermittent anorectic therapy in obesity.BMJ, 1968